Stay updated on Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3; core study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-11T14:46:35.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    An updated site revision tag (v3.4.2) was added, and an existing government funding status notice (v3.4.1) was removed. The study’s content and data remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T02:13:35.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice and status update were added to the page footer. The site revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:39:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0). Removed the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T00:27:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:52:04.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section including Missouri (St. Louis, MO) for the study page and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:54:33.000Z thumbnail image

Stay in the know with updates to Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib and Ruxolitinib in Myelofibrosis Clinical Trial page.